Indivior Pharmaceuticals Inc (INDV) Financials

INDV Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.2 billion 1.4 billion
March 31, 2026 1.2 billion 1.3 billion
Dec. 31, 2025 1.2 billion 1.3 billion
Sept. 30, 2025 1.4 billion 1.6 billion

INDV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 222.0 million 20.0 million
March 31, 2026 -29.0 million 9.0 million
Dec. 31, 2025 -245.0 million 5.0 million
Sept. 30, 2025 -59.0 million 7.0 million

INDV Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 122.0 million
March 31, 2026 89.0 million
Dec. 31, 2025 102.0 million
Sept. 30, 2025 43.0 million

INDV Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 222.0 million 487.0 million 13.0 million
March 31, 2026 175.0 million 486.0 million 14.0 million
Dec. 31, 2025 195.0 million 290.0 million 22.0 million
Sept. 30, 2025 445.0 million 304.0 million 34.0 million

INDV Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 129.0 million
March 31, 2026 129.0 million
Dec. 31, 2025 125.0 million
Sept. 30, 2025 129.0 million

INDV Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 7.0 million 12.0 million 122.0 million -
March 31, 2026 20.0 million 16.0 million 124.0 million -
Dec. 31, 2025 24.0 million 17.0 million 155.0 million 67.0 million
Sept. 30, 2025 20.0 million 20.0 million 133.0 million -

INDV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 343.0 million 49.0 million
March 31, 2026 317.0 million 40.0 million
Dec. 31, 2025 358.0 million 64.0 million
Sept. 30, 2025 314.0 million 62.0 million

INDV Revenue by Segment
Graph available only for paid members. Upgrade to see it.

INDV

Price: $34.16

52 week price:
22.95
42.81

Earnings Per Share: 2.79 USD

P/E Ratio: 13.79

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 4.5 billion

Links: